Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Fayon

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
ERJ Open Research|July 29, 2021
The lower respiratory airway wall in children in health and diseaseMichael Fayon, Fabien Beaufils
Pediatric Pulmonology|October 25, 2024
Predicting exacerbations in severe preschool wheezersMichael Fayon, Fabien Beaufils
Pediatric Pulmonology|November 28, 2023
Home-spirometry exacerbation profiles in children with cystic fibrosisBenoit Bouteleux, Fabien Beaufils, Michael Fayon, et al.
The European Respiratory Journal|July 13, 2013
Clinimetric properties of bronchoalveolar lavage inflammatory markers in cystic fibrosisMichael Fayon, Lisa Kent, Stephanie Bui, et al.
The Pediatric Infectious Disease Journal|July 16, 2015
Persistent Infection Because of Pandoraea sputorum in a Young Cystic Fibrosis Patient Resistant to Antimicrobial TreatmentMathilde Pugès, Stéphane Debelleix, Michael Fayon, et al.
Pediatric Pulmonology|May 10, 2002
Differential effect of dexamethasone and hydrocortisone on alveolar growth in rat pupsMichael Fayon, Philippe Jouvencel, Dominique Carles, et al.
Frontiers in Pediatrics|May 31, 2022
Prevalence and Determinants of Wheezing and Bronchodilatation in Children With Cystic Fibrosis: A Retrospective Cohort StudyFrancois Galodé, O Ladipo, A Andrieux, et al.
Healthcare (Basel, Switzerland)|August 27, 2021
The First 1000 Days: Impact of Prenatal Tobacco Smoke Exposure on Hospitalization Due to Preschool WheezingCyrielle Collet, Michael Fayon, Florence Francis, et al.
Therapeutic Drug Monitoring|December 21, 2020
A Population Pharmacokinetic Modeling Approach to Determine the Efficacy of Intravenous Amikacin in Children with Cystic FibrosisJean-Baptiste Woillard, Stéphane Bouchet, Michael Fayon, et al.
Pediatric Pulmonology|June 17, 2020
Impact at school age of early chronic methicillin-sensitive Staphylococcus aureus infection in children with cystic fibrosisFrançois Galodé, Gael Dournes, Jean-François Chateil, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
ERJ Open Research|July 29, 2021
The lower respiratory airway wall in children in health and diseaseMichael Fayon, Fabien Beaufils
Pediatric Pulmonology|October 25, 2024
Predicting exacerbations in severe preschool wheezersMichael Fayon, Fabien Beaufils
Pediatric Pulmonology|November 28, 2023
Home-spirometry exacerbation profiles in children with cystic fibrosisBenoit Bouteleux, Fabien Beaufils, Michael Fayon, et al.
The European Respiratory Journal|July 13, 2013
Clinimetric properties of bronchoalveolar lavage inflammatory markers in cystic fibrosisMichael Fayon, Lisa Kent, Stephanie Bui, et al.
The Pediatric Infectious Disease Journal|July 16, 2015
Persistent Infection Because of Pandoraea sputorum in a Young Cystic Fibrosis Patient Resistant to Antimicrobial TreatmentMathilde Pugès, Stéphane Debelleix, Michael Fayon, et al.
Pediatric Pulmonology|May 10, 2002
Differential effect of dexamethasone and hydrocortisone on alveolar growth in rat pupsMichael Fayon, Philippe Jouvencel, Dominique Carles, et al.
Frontiers in Pediatrics|May 31, 2022
Prevalence and Determinants of Wheezing and Bronchodilatation in Children With Cystic Fibrosis: A Retrospective Cohort StudyFrancois Galodé, O Ladipo, A Andrieux, et al.
Healthcare (Basel, Switzerland)|August 27, 2021
The First 1000 Days: Impact of Prenatal Tobacco Smoke Exposure on Hospitalization Due to Preschool WheezingCyrielle Collet, Michael Fayon, Florence Francis, et al.
Therapeutic Drug Monitoring|December 21, 2020
A Population Pharmacokinetic Modeling Approach to Determine the Efficacy of Intravenous Amikacin in Children with Cystic FibrosisJean-Baptiste Woillard, Stéphane Bouchet, Michael Fayon, et al.
Pediatric Pulmonology|June 17, 2020
Impact at school age of early chronic methicillin-sensitive Staphylococcus aureus infection in children with cystic fibrosisFrançois Galodé, Gael Dournes, Jean-François Chateil, et al.
Pageof 8